Enhanced MR for morphological characterization of ligaments, tendons and bone

Information

  • Research Project
  • 10246251
  • ApplicationId
    10246251
  • Core Project Number
    U01EB023829
  • Full Project Number
    5U01EB023829-03
  • Serial Number
    023829
  • FOA Number
    PAR-16-116
  • Sub Project Id
  • Project Start Date
    8/5/2020 - 4 years ago
  • Project End Date
    7/31/2025 - 6 months from now
  • Program Officer Name
    WANG, SHUMIN
  • Budget Start Date
    8/1/2021 - 3 years ago
  • Budget End Date
    7/31/2022 - 2 years ago
  • Fiscal Year
    2021
  • Support Year
    03
  • Suffix
  • Award Notice Date
    9/14/2021 - 3 years ago

Enhanced MR for morphological characterization of ligaments, tendons and bone

PROJECT SUMMARY/ABSTRACT According to Council for Disability Awareness, diseases of the musculoskeletal system and connective tissue, such as the ligaments, tendons and bone are the #1 cause of disability in the United States. MR imaging has been increasingly becoming the diagnostic tool of choice for evaluation and management of these diseases and injuries due to its potential of providing information on not only anatomic structure but also function noninvasively. However, the capability of MRI in studying human ligaments, tendons and bone is limited by inadequate sensitivity and slow acquisitions of conventional MR technology. Semi-solid/solid tissues, including collagen-rich tissues such as calcified ligaments and tendons, as well as periosteum, cortical bone and trabecular bone, provide very little MR signal with traditional MRI due to their very short transverse (T2) relaxation time of a few milliseconds or less. In addition, during the long acquisition times, involuntary movements of human subjects introduce motion artifacts, posing a critical challenge in obtaining high- resolution images with diagnostic value. Several recently developed technologies have the potential to address these limitations. Ultrahigh field 7T MRI, parallel imaging, and compressed sensing have demonstrated unique advantages of high sensitivity and fast acquisitions in vivo. Studies on musculoskeletal imaging using ultra- short echo time (UTE) and zero echo time (ZTE) methods have shown unparalleled capability to image short T2 species normally invisible in MRI. However, the implementation of these technologies at ultrahigh fields is challenging due to design difficulties of the required high frequency multichannel coil arrays, as well as the problems associated with ultrahigh fields, e.g. increased susceptibility, B1 inhomogeneity, and increased SAR. In this study, through a synergistic bioengineering research partnership, we propose a comprehensive project for developing advanced hardware and imaging methods at 7T to enable morphological and functional characterization of human ligaments, tendons and bone. These developments aim to produce highly sensitive, isotropic ~100-150um resolution images of semi-solid connective tissues with clinically relevant contrast in 1 minute scan time. Hardware developments will include multichannel coil arrays for knee and extremities using quadrature and flexible array technology with metamaterial decoupling, as well as application of pyrolytic graphite materials for reducing susceptibility artifacts. Imaging acquisition developments will be based on improved UTE/ZTE sequences, and we propose new integrated techniques for improved semi-solid tissue contrast, motion correction, and acceleration using parallel imaging and compressed sensing. We will also validate the methods developed and assess the performance and safety/SAR. This research would provide sensitive imaging tools for morphological and functional characterization of ligaments, tendons and bone, which are highly demanded and essential for studying semi-solid connective tissues. We expect this research will have a long-term clinical impact in the management of musculoskeletal system diseases and injuries.

IC Name
NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING
  • Activity
    U01
  • Administering IC
    EB
  • Application Type
    5
  • Direct Cost Amount
    590548
  • Indirect Cost Amount
    138384
  • Total Cost
    728932
  • Sub Project Total Cost
  • ARRA Funded
    False
  • CFDA Code
    286
  • Ed Inst. Type
    BIOMED ENGR/COL ENGR/ENGR STA
  • Funding ICs
    NIBIB:728932\
  • Funding Mechanism
    Non-SBIR/STTR RPGs
  • Study Section
    ZRG1
  • Study Section Name
    Special Emphasis Panel
  • Organization Name
    STATE UNIVERSITY OF NEW YORK AT BUFFALO
  • Organization Department
    BIOMEDICAL ENGINEERING
  • Organization DUNS
    038633251
  • Organization City
    AMHERST
  • Organization State
    NY
  • Organization Country
    UNITED STATES
  • Organization Zip Code
    142282567
  • Organization District
    UNITED STATES